Advertisement

Related Videos

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Welcome and Introduction to Vi3C

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

David A. Hyman, MD, JD, on Inclusive Shared Savings

Daniel Goldstein, MD: Interventional Pharmacoeconomics - Why and How

Advertisement

Advertisement




Mar
17
Today In Oncology
Romiplostim Improves Chemotherapy-Induced Thrombocytopenia in GI Cancers
Benmelstobart Plus Anlotinib in First-Line Treatment for PD-L1–Positive Advanced NSCLC
Optical Genome Mapping Detects Additional Genetic Variants in Nearly 20% of Individuals With Acute Leukemia
New Prostate Cancer Risk Classification With PSMA-PET
FDA Consolidates Systems Into One Cohesive Adverse Event Monitoring Tool
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo